Back to results
US 11,597,738 B2Granted
Psilocin derivatives as serotonergic psychedelic agents for the treatment of CNS disorders
AssigneeMindset Pharma Inc.
InventorsAbdelmalik Slassi, Joseph Araujo
Life of this patent
Estimating the term…
Abstract
The present application relates to psilocin derivatives of Formula (I), to processes for their preparation, to compositions comprising them and to their use in activation of a serotonin receptor in a cell, as well as to treating diseases, disorders or conditions by activation of a serotonin receptor in a cell.
Claims29
A compound of Formula I-2 or a pharmaceutically acceptable salt, solvate or prodrug thereof:
A compound of Formula I-2, or a pharmaceutically acceptable salt or solvate thereof:
Dependencies are inferred from the claim text.